These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7684652)

  • 1. Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.
    Dohi Y; Sunada S; Aoki M; Moriguchi A; Okabayashi M; Miyata M; Matsuda H
    Cancer Immunol Immunother; 1993 Jun; 36(6):357-63. PubMed ID: 7684652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
    Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
    Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice.
    Forster K; Goethel A; Chan CW; Zanello G; Streutker C; Croitoru K
    Gastroenterology; 2012 Nov; 143(5):1298-1307. PubMed ID: 22819863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.
    Harada M; Okamoto T; Omoto K; Tamada K; Takenoyama M; Hirashima C; Ito O; Kimura G; Nomoto K
    Immunology; 1996 Mar; 87(3):447-53. PubMed ID: 8778032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and proliferation of splenocytes and lymph node cells from adjuvant-treated nude mice. Studies of natural and in vitro activation.
    Radzikowski C; Rygaard J; Budzyński W; Salwa J; Stenvang JP; Schou M; Lorenzen L; Zeuthen J
    APMIS; 1996 Sep; 104(9):647-58. PubMed ID: 8972689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
    J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
    Stanková J; Hoskin DW; Roder JC
    Cell Immunol; 1989 Jun; 121(1):13-29. PubMed ID: 2470516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.
    Li Q; Yu B; Grover AC; Zeng X; Chang AE
    J Immunother; 2002; 25(4):304-13. PubMed ID: 12142553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory-signal-providing cells.
    Okamoto T; Harada M; Shinomiya Y; Matsuzaki G; Nomoto K
    Cancer Immunol Immunother; 1995 Mar; 40(3):173-81. PubMed ID: 7728776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid killing of murine lymph node T blasts by intestinal intraepithelial lymphocytes in vitro.
    Kawamoto Y; Sasaki K; Kato Y; Kojima K; Tsuji T; Miyama A
    Eur J Immunol; 1996 Mar; 26(3):653-8. PubMed ID: 8605934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
    Melgar S; Bas A; Hammarström S; Hammarström ML
    Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cell-mediated cytotoxicity (NCMC) against NK-sensitive tumours in vitro by murine spleen Ly-6C+ natural T cells.
    Martiniello R; Burton RC; Smart YC
    Int J Cancer; 1997 Feb; 70(4):450-60. PubMed ID: 9033654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-1 alpha on the in vitro activation of tumor-draining lymph node cells for adoptive immunotherapy.
    Hammel JM; Tuck MK; Hain JM; Chang AE; Sondak VK
    J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):1-12. PubMed ID: 8081555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.